These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1906228)

  • 1. Sulfur conjugates as putative pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Huxtable RJ; Bowers R; Mattocks AR; Michnicka M
    Adv Exp Med Biol; 1991; 283():605-12. PubMed ID: 1906228
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms for pyrrolizidine alkaloid activation and detoxification.
    Buhler DR; Miranda CL; Kedzierski B; Reed RL
    Adv Exp Med Biol; 1991; 283():597-603. PubMed ID: 2069028
    [No Abstract]   [Full Text] [Related]  

  • 3. 7-Glutathione-pyrrole and 7-cysteine-pyrrole are potential carcinogenic metabolites of pyrrolizidine alkaloids.
    He X; Xia Q; Fu PP
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2017 Apr; 35(2):69-83. PubMed ID: 28418776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Lafranconi WM; Ohkuma S; Huxtable RJ
    Toxicon; 1985; 23(6):983-92. PubMed ID: 3938082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo.
    Wang YP; Fu PP; Chou MW
    Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung.
    Lafranconi WM; Huxtable RJ
    Biochem Pharmacol; 1984 Aug; 33(15):2479-84. PubMed ID: 6087830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
    Roth RA; Reindel JF
    Adv Exp Med Biol; 1991; 283():477-87. PubMed ID: 1906225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glutathione and cysteine on pyrrolizidine alkaloid-induced hepatotoxicity and DNA adduct formation in rat primary hepatocytes.
    He X; Xia Q; Shi Q; Fu PP
    J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):109-123. PubMed ID: 32500832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver.
    Mattocks AR; Croswell S; Jukes R; Huxtable RJ
    Toxicon; 1991; 29(4-5):409-15. PubMed ID: 1907409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
    Couet CE; Hopley J; Hanley AB
    Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7-cysteine-pyrrole conjugate: A new potential DNA reactive metabolite of pyrrolizidine alkaloids.
    He X; Xia Q; Ma L; Fu PP
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2016; 34(1):57-76. PubMed ID: 26761716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat.
    Yan CC; Huxtable RJ
    Toxicon; 1995 May; 33(5):627-34. PubMed ID: 7660367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethoxyquin on the toxicity of the pyrrolizidine alkaloid monocrotaline and on hepatic drug metabolism in mice.
    Miranda CL; Carpenter HM; Cheeke PR; Buhler DR
    Chem Biol Interact; 1981 Oct; 37(1-2):95-107. PubMed ID: 6793254
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids.
    Song Z; He Y; Ma J; Fu PP; Lin G
    J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):124-140. PubMed ID: 32500835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and pulmonary toxicity of pyrrolizidine alkaloids.
    Huxtable RJ
    Pharmacol Ther; 1990; 47(3):371-89. PubMed ID: 2290854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione.
    Robertson KA; Seymour JL; Hsia MT; Allen JR
    Cancer Res; 1977 Sep; 37(9):3141-4. PubMed ID: 884667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo.
    Yang YC; Yan J; Doerge DR; Chan PC; Fu PP; Chou MW
    Chem Res Toxicol; 2001 Jan; 14(1):101-9. PubMed ID: 11170513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cells augment transport of reactive metabolites of monocrotaline from liver to lung in isolated and tandem liver and lung preparations.
    Pan LC; Lamé MW; Morin D; Wilson DW; Segall HJ
    Toxicol Appl Pharmacol; 1991 Sep; 110(2):336-46. PubMed ID: 1909819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.